Table 1 Clinicopathologic characteristics of patients in the operative and conservative treatment group.
Variable | Operative treatment n = 44 (%) | Conservative treatment n = 143 (%) | p-value |
---|---|---|---|
Age (years) mean ± SD | 66 ± 14 | 58 ± 14 | < 0.001 |
Gender n (%) | |||
 Male | 27 (61.4) | 80 (55.9) | 0.525 |
 Female | 17 (38.6) | 63 (44.1) | |
Charlson Index mean ± SD | 4.12 ± 3.89 | 2.11 ± 2.23 | < 0.001 |
Shock n (%) | |||
 No | 35 (79.5) | 121 (98.6) | < 0.001 |
 Yes | 9 (20.5) | 2 (1.4) | |
Positive Blumberg sign n (%)** | |||
 No | 22 (61.4) | 114 (79.7) | 0.013 |
 Yes | 11 (38.6) | 29 (20.3) | |
Glycemia mean ± SD | 125 ± 35 | 111 ± 33 | 0.017 |
Creatinine mean ± SD | 1.14 ± 1.57 | 0.98 ± 0.73 | 0.349 |
Hemoglobin mean ± SD | 12.99 ± 1,99 | 15,04 ± 18,36 | 0.467 |
WBC mean ± SD | 13,50 ± 5,53 | 13,25 ± 4,13 | 0.785 |
PLT mean ± SD | 307 ± 289 | 267 ± 104 | 0.375 |
Abs neutrophil count | 11.36 ± 5.12 | 10.52 ± 4.01 | 0.325 |
Abs lymph count | 1.43 ± 0.84 | 1.80 ± 0.90 | 0.017 |
N/L ratio | 10.40 ± 8.22 | 7.49 ± 6.57 | 0.038 |
P/L ratio | 327.78 ± 574.40 | 267.21 ± 104.87 | 0.099 |
Previous conservative treatment n (%) | |||
 No | 33 (75) | 127 (88.8) | 0.023 |
 Yes | 11 (25) | 16 (11.2) | |
WSES Stage n (%) | |||
 Stage 0 | 0 (0) | 12 (8.4) | < 0.001 |
 Stage Ia | 7 (15.9) | 55 (38.5) | |
 Stage Ib | 9 (20.5) | 39 (27.3) | |
 Stage IIa | 12 (27.3) | 22 (15.4) | |
 Stage IIb | 16 (36.4) | 15 (10.5) | |
Sigmoid thickening n (%) | |||
 No | 5 (11.4) | 3 (2.1) | 0.019 |
 Yes | 39 (88.6) | 140 (97.9) | |
Pericolic collection n (%) | |||
 No | 21 (47.7) | 79 (52.2) | 0.382 |
 Yes | 23 (52.3) | 74 (44.8) | |
Pelvic fluid n (%)a | |||
 No | 23 (53.5) | 91 (64.5) | 0.191 |
 Yes | 20 (46.5) | 50 (35.5) | |
Extrapelvic fluid n (%)b | |||
 No | 35 (85.4) | 128 (90.1) | 0.399 |
 Yes | 6 (14.6) | 14 (9.9) | |
Pericolic air n (%)c | |||
 No | 19 (45.2) | 68 (47.9) | 0.763 |
 Yes | 23 (54.8) | 74 (52.1) | |
Distant air n (%)d | |||
 No | 27 (62.8) | 129 (90.8) | < 0.001 |
 Yes | 16 (37.2) | 13 (9.2) |